We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: Graphical Abstract (Eldad D. Shulman et al., AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology, Cell (2026). DOI: 10.1016/j.cell.2026.04.023)

Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images

An AI approach predicts tumor spatial gene expression from biopsy images, enabling fast, low-cost mapping for biomarker studies. More...
18 May 2026
Image: New findings indicate that clonal hematopoiesis, an established prognostic factor in blood cancers, is associated with worse survival in patients with solid tumors (image credit: Adobe Stock)

Tumor Microenvironment Marker Linked to Worse Survival in Solid Tumors

New data links tumor-infiltrating clonal hematopoiesis in solid tumors to worse survival. More...
18 May 2026
Image: Signatera CDx uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

FDA-Approved MRD Blood Test Guides Adjuvant Bladder Cancer Therapy

Natera’s Signatera CDx has been approved by the U.S. FDA as a companion diagnostic for use with adjuvant atezolizumab in MIBC. More...
18 May 2026
Image: Findings show that genetic changes inside cancer cells may help explain why some patients with gallbladder cancer have poorer outcomes despite similar treatment (image credit: 123RF)

Tumor Genomic Profiling Identifies High-Risk Gallbladder Cancer

New findings link actionable tumor DNA alterations to shorter survival in gallbladder cancer, informing risk stratification. More...
18 May 2026
Image: The technology leverages routine slide preparations to deliver an individualized risk readout based on image-derived signals (photo courtesy of Valar Labs)

AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification

An AI-enabled pathology test gains FDA Breakthrough status to stratify bladder cancer risk from routine H&E slides. More...
18 May 2026
Image: The study frames predictive genomic screening as both a clinical opportunity and a systems challenge (photo courtesy of Mayo Clinic)

Genome Sequencing Uncovers Hidden Genetic Risks in Healthy Adults

Predictive genome sequencing in healthy adults uncovers hidden actionable risks and defines workflows to enable care. More...
18 May 2026
Image: FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate (Zhao, J., Yao, J., Hosseini, H., et al. Histopathology (2026). doi.org/10.1111/his.70166)

Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer

Researchers have identified a sensitive protein marker aiding diagnosis of  difficult-to-classify prostate tumors. More...
15 May 2026
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Rapid Sepsis Test
SeptiCyte RAPID
ADLM